A look at the results of the recently completed project, which aimed to develop an holistic monitoring system via process integration to more effectively control clinical trial risks beyond isolated RBM strategies.
María Proupín-Pérez, PhD
Advertisement
Articles by María Proupín-Pérez, PhD
This guidance document will offer information about RbM strategies.
Advertisement
Latest Updated Articles
RbM Guidance Document: Ten Burning Questions about Risk-Based Study ManagementPublished: January 13th 2015 | Updated:
The PUEKS Project: Process Innovation in Clinical Trial MonitoringPublished: August 22nd 2017 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
A Look Back: AI and Pragmatic Trials Took Center Stage at SCOPE Summit 2025
2
ACT Brief: AI Innovations, Vision Trial Breakthroughs, and a Major Industry Acquisition
3
Bringing Clinical Trials Into the Digital Era with eConsent
4
Genentech’s Phase III MEERKAT and SANDCAT Trials Show Vision and Anatomical Gains With Vamikibart in Uveitic Macular Edema
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
